Oat compound shows promise for inflammation in early human trial
NCT ID NCT06101784
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested avenanthramide, a natural compound found in oats, to see if it is safe and how the body processes it. Researchers gave single and multiple doses to 92 healthy volunteers and people with low-grade inflammation. The goal was to check for side effects and measure levels of the compound in the blood, not yet to prove it reduces inflammation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- avenanthramide (an oat compound)
- What this could lead to
- If it works, this could point toward a natural supplement to help manage low-grade inflammation.
- What could go wrong
- This is a very early, first-in-human study focused on safety, not on proving the compound works. The results may not lead to any treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Montreal Heart Institute
Montreal, Quebec, H1T 1N6, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a gentle yoga practice turn down the Body's pain and inflammation?
- Could a stress hormone be behind the hidden danger of low blood sugar?
- Grape powder may help aging immune systems — a trial puts it to the test
- A simple blood pressure cuff trick could shield the heart in kidney disease
- Can a sedative help rebuilt tissue survive after cancer surgery?
- Laser light may soothe brace pain without drugs